大环状钆基对比剂钆布醇与钆特醇在兔多次静脉注射后脑内消除动力学相似
研究用雄性新西兰白兔分两组各21只,5天内接受3次0.9 mmol Gd/kg的钆布醇或钆特醇静脉注射,对照组9只注射生理盐水,于2、6、12周测定小脑、大脑、血液和尿液中钆浓度。两种大环状对比剂在各时间点脑组织钆浓度均无显著差异(P > 0.05),12周时尿中排出的钆仍为完整钆络合物形式。结论与在大鼠中报道的结果相反,兔脑组织消除动力学无显著差异。
要点
- 钆布醇与钆特醇在兔脑小脑和大脑的钆浓度各时间点均无显著差异(P > 0.05)。
- 两种对比剂脑内钆浓度从2周到12周均下降,12周时血浆钆浓度低于定量下限(<0.005 nmol Gd/mL)。
- 12周时尿中排出的钆仍以完整钆络合物化学形式存在。
核心结论
- 与在大鼠中报道的结果相反,兔多次静脉注射大环状钆基对比剂钆布醇和钆特醇后,脑组织消除动力学无显著差异。
研究设计与样本
- 动物实验:雄性新西兰白兔(2.4–3.1 kg),2个研究组各21只,分别接受钆布醇或钆特醇3次静脉注射(0.9 mmol Gd/kg,5天内完成,总剂量2.7 mmol Gd/kg)。
- 对照组9只接受3次生理盐水注射(1.8 mL/kg)。
- 于2、6、12周,每组各7只研究组动物和3只对照组动物被处死,用 inductively coupled plasma mass spectrometry 测定小脑、大脑、血液和尿液中钆浓度,用 high pressure liquid chromatography 测定尿中排出的钆化学形态。
诊断标准与关键数值
- 钆布醇组小脑和大脑平均钆浓度从2周的0.26和0.21 nmol Gd/g降至12周的0.040和0.027 nmol Gd/g。
- 钆特醇组小脑和大脑平均钆浓度从2周的0.25和0.21 nmol Gd/g降至12周的0.037和0.023 nmol Gd/g。
- 血浆钆浓度从2周时钆布醇组0.11 nmol Gd/mL和钆特醇组0.13 nmol Gd/mL降至12周时低于定量下限(<0.005 nmol Gd/mL)。
- 两种对比剂尿钆浓度在2至6周和6至12周均呈双相下降过程。
- 12周时两种对比剂尿中排出的钆仍以完整钆络合物化学形式存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
MATERIALS AND METHODS: Male white New Zealand rabbits (2.4-3.1 kg) in 2 study groups (n = 21 each) received 3 injections of either gadobutrol or gadoteridol at 0.9 mmol Gd/kg within 5 days (total dose, 2.7 mmol Gd/kg). Animals in one control group (n = 9) received 3 injections of saline (1.8 mL/kg). After 2, 6, and 12 weeks, 7 animals from each study group and 3 from the control group were killed and the Gd concentrations in the cerebellum, cerebrum, in blood and in urine were determined by inductively coupled plasma mass spectrometry. The chemical species of excreted Gd in urine were determined by high pressure liquid chromatography.
RESULTS: No significant (P > 0.05) differences in the Gd concentrations in the brain of rabbits were observed between the 2 macrocyclic GBCAs gadoteridol and gadobutrol at all time points. In the gadobutrol group, the mean Gd concentrations in the cerebellum and cerebrum decreased from 0.26 and 0.21 nmol Gd/g after 2 weeks, to 0.040 and 0.027 nmol Gd/g after 12 weeks, respectively, and in the gadoteridol group, from 0.25 and 0.21, to 0.037 and 0.023 nmol Gd/g, respectively. The plasma levels decreased from 0.11 and 0.13 nmol Gd/mL at 2 weeks for gadobutrol and gadoteridol to below the limit of quantification (<0.005 nmol Gd/mL) at 12 weeks. The urine concentration dropped in a biphasic course from 2 to 6 and from 6 to 12 weeks for both agents. The Gd excreted after 12 weeks was still present in the urine in the chemical form of the intact Gd complex for both agents.
CONCLUSIONS: Contrary to what had been reported in rats, no significant differences in the elimination kinetics from brain tissue in rabbits were observed after intravenous injection of multiple doses of the macrocyclic GBCAs gadobutrol and gadoteridol.
引用
- Frenzel T, Ulbrich HF, Pietsch H, et al. The Macrocyclic Gadolinium-Based Contrast Agents Gadobutrol and Gadoteridol Show Similar Elimination Kinetics From the Brain After Repeated Intravenous Injections in Rabbits. Invest Radiol. 2021. PMID: 33259443. doi:10.1097/RLI.0000000000000749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。